15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size).

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Prostaglandins & other lipid mediators

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.PROSTAGLANDINS.2006.05.022PMID 17164141
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.

  2005cited by this paper
• Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.

  2005cited by this paper
• Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells

  2005cited by this paper
• Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cells

  2004cited by this paper
• 15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation.

  2004cited by this paper
• Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398.

  2003cited by this paper
• Deletion, mutation, and loss of expression of KLF6 in human prostate cancer.

  2003cited by this paper
• Subcellular Localization and Tumor-suppressive Functions of 15-Lipoxygenase 2 (15-LOX2) and Its Splice Variants*

  2003cited by this paper
• The Role of Calpain in the Proteolytic Cleavage of E-cadherin in Prostate and Mammary Epithelial Cells*

  2003cited by this paper
• Hypermethylation of GSTP1, CD44, and E‐cadherin genes in prostate cancer among US Blacks and Whites

  2003cited by this paper
• The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer.

  2003cited by this paper
• Cellular senescence in the pathogenesis of benign prostatic hyperplasia

  2003cited by this paper
• Evidence That Arachidonate 15-Lipoxygenase 2 Is a Negative Cell Cycle Regulator in Normal Prostate Epithelial Cells* 210

  2002cited by this paper
• Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma.

  2001cited by this paper
• 15-Lipoxygenase-2 expression in benign and neoplastic sebaceous glands and other cutaneous adnexa.

  2001cited by this paper
• KLF6, a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer

  2001cited by this paper
• Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer.

  2001cited by this paper
• Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas.

  2001cited by this paper
• Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate.

  2001cited by this paper
• Decreased expression of catenins (α and β), p120 CTN, and E‐cadherin cell adhesion proteins and E‐cadherin gene promoter methylation in prostatic adenocarcinomas

  2001cited by this paper
• Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia.

  2000cited by this paper
• Differential characteristics of human 15-lipoxygenase isozymes and a novel splice variant of 15S-lipoxygenase.

  1999cited by this paper
• 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma.

  1999cited by this paper
• Discovery of a second 15S-lipoxygenase in humans.

  1997cited by this paper

• Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer

  2024cites this paper
• Lipoxygenases at the Intersection of Infection and Carcinogenesis

  2024cites this paper
• p53 Activates the Lipoxygenase Activity of ALOX15B via Inhibiting SLC7A11 to Induce Ferroptosis in Bladder Cancer Cells.

  2023cites this paper
• Ferroptosis landscape in prostate cancer from molecular and metabolic perspective

  2023cites this paper
• Epigenetic regulation of 15-lipoxygenase-1 expression in human chondrocytes by promoter methylation

  2023cites this paper
• Growth State-Dependent Expression of Arachidonate Lipoxygenases in the Human Endothelial Cell Line EA.hy926

  2022cites this paper
• Arachidonate 15-lipoxygenase type B: Regulation, function, and its role in pathophysiology

  2022influential citation
• Progression from Monoclonal gammopathy of undetermined significance of the immunoglobulin M class (IgM-MGUS) to Waldenstrom Macroglobulinemia is associated with an alteration in lipid metabolism

  2021cites this paper
• Human enteric glial cells are defective for 15-HETE production and epithelial permeability control in Crohn’s disease

  2021cites this paper
• 15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged sword

  2021cites this paper
• Arachidonate 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid contribute to stromal aging-induced progression of pancreatic cancer

  2020cites this paper
• Neoplasms of the Prostate

  2020cites this paper
• Regulation and Functions of 15-Lipoxygenases in Human Macrophages

  2019influential citation
• Do lipoxygenases occur in viruses?: Expression and characterization of a viral lipoxygenase-like protein did not provide evidence for the existence of functional viral lipoxygenases.

  2018cites this paper
• Decreases in 15-lipoxygenase metabolites in Olmsted syndrome model rats.

  2017cites this paper
• Defects in 15-HETE Production and Control of Epithelial Permeability by Human Enteric Glial Cells From Patients With Crohn's Disease.

  2016cites this paper
• INHIBITORS OF LEUKOTRIENES SYNTHESIS: NOVEL AGENTS AND THEIR IMPLEMENTATION.

  2016cites this paper
• The Physiology and Pathophysiology of Lipoxygenases in the Skin

  2016cites this paper
• Lipids and Skin Health

  2015cites this paper
• Mammalian lipoxygenases and their biological relevance.

  2015cites this paper
• Comprehensive Proteomic and Metabolomic Signatures of Nontypeable Haemophilus influenzae-Induced Acute Otitis Media Reveal Bacterial Aerobic Respiration in an Immunosuppressed Environment*

  2015cites this paper
• Transcriptional regulation of BNIP3 by Sp3 in prostate cancer

  2015cites this paper
• Potency of non-steroidal anti-inflammatory drugs in chemotherapy.

  2015cites this paper
• Potency of non-steroidal anti-inflammatory drugs in chemotherapy (Review)

  2015cites this paper
• Metabolic and Structural Functions of Lipoxygenases in Skin

  2015cites this paper
• The role of lipoxygenases in epidermis.

  2014cites this paper
• Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer

  2014cites this paper
• Chapter The Role of Cyclooxygenases and Lipoxygenases in the Regulation of Tumor Angiogenesis

  2013cites this paper
• A Summary of the Prostate Cancer Prevention Trials With a Focus on the Role of Vitamin E

  2013cites this paper
• Are Lipoxygenases Valid Targets of Cancer Prevention and Treatment

  2012cites this paper
• Molecular characterization of EP6--a novel imidazo[1,2-a]pyridine based direct 5-lipoxygenase inhibitor.

  2012cites this paper
• 15-Lipoxygenase Metabolites of Docosahexaenoic Acid Inhibit Prostate Cancer Cell Proliferation and Survival

  2012influential citation
• Cyclooxygenases and lipoxygenases in cancer

  2011cites this paper
• Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse.

  2011cites this paper
• Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.

  2011cites this paper
• Global gene expression profiling in early-stage polycystic kidney disease in the Han:SPRD Cy rat identifies a role for RXR signaling.

  2011cites this paper
• 12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms.

  2011cites this paper
• Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention

  2011cites this paper
• Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.

  2011cites this paper
• Lipoxygenase inhibitors for cancer prevention: promises and risks.

  2010cites this paper
• Absence of glutathione peroxidase 4 affects tumor angiogenesis through increased 12/15-lipoxygenase activity.

  2010cites this paper
• Dietary omega-3 polyunsaturated fatty acids and cancer

  2010cites this paper
• Genes Encoding Enzymatic Activities Implicated in the Eicosanoid Cascade of Arachidonic Acid and their Receptors are Expressed at mRNA Levels in Human Meningiomas

  2010cites this paper
• TRANSGENIC EXPRESSION OF 15-LIPOXYGENASE 2 (15-LOX2) IN MOUSE PROSTATE LEADS TO HYPERPLASIA AND CELL SENESCENCE

  2010influential citation
• 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer

  2010cites this paper
• Fatty Acid Metabolism Mediated by 12/15-Lipoxygenase is a Novel Regulator of Hematopoietic Stem Cell Function and Myelopoiesis

  2010cites this paper
• ω-3 PUFAs, Breast and Prostate Cancer: Experimental Studies

  2010cites this paper
• 15-Lipoxygenase-1 in Colorectal Cancer: A Review

  2009cites this paper
• Kinetic and structural investigations of the allosteric site in human epithelial 15-lipoxygenase-2.

  2009cites this paper
• Gamma Tocopherol Upregulates the Expression of 15-S-HETE and Induces Growth Arrest Through a PPAR Gamma-Dependent Mechanism in PC-3 Human Prostate Cancer Cells

  2009cites this paper
• Roles of Eicosanoids in Prostate Cancer.

  2008cites this paper
• Dietary n-3 polyunsaturated fatty acids enhance hormone ablation therapy in androgen-dependent prostate cancer.

  2008cites this paper
• 5-LOX, 12-LOX and 15-LOX in immature forms of human leukemic blasts.

  2008cites this paper
• Expression profiling of CD133+ and CD133— epithelial cells from human prostate

  2008cites this paper
• Eicosanoids in tumor progression and metastasis.

  2008cites this paper
• Lipoxygenase metabolism: roles in tumor progression and survival

  2007cites this paper